Auransa

Auransa is an AI-driven platform for discovering drugs with new pharmacology from large amounts of genomic data collected from human disease tissues. The company's platform is used to study molecular disease subtypes and predict compounds and targets for responsive patient populations. The current internal drug pipeline includes cancer and other diseases. The company has established partnerships with companies and institutions in the biopharmaceutical industry.